Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

FDA Approves Bayer’s New Drug for Seco

Bayer announced approval of new drug Sunharbo (Asundexian) by USFDA to reduce the risk of

India Proposes New Batch Release Require

The Government of India has issued draft notification G.S.R. 955(E) dated 28 October 2026, proposing

India Proposal for Immediate Suspension

The Government of India has issued a draft notification, G.S.R. 956(E), proposing a significant amendment

CDSCO Renews Push for ONDLS Registration

On 27 October, CDSCO issued a circular directing State Drug Controllers to ensure that vendors

Baxter Warning Letter Highlights Beta-La

Baxter International Inc, was issued an FDA Warning Letter following cGMP violations observed during an

Medical Device Labels in India To Displa

The Ministry of Health and Family Welfare, Government of India has issued the Medical Devices

Strides FDA 483 Flags Lapses in Microbio

The USFDA issued a Form 483 to Strides Pharma Sciences Ltd., Bangalore facility (FEI 3004554612)

Aurobindo’s Eugia Facility Classified

Aurobindo’s Eugia Pharma Specialities Limited (FEI 3011960448), located at Shameerpet, India, has been classified OAI

FDA Warning Letter to Simtra Biopharma F

The U.S. FDA has issued a Warning Letter to Simtra BioPharma Solutions following cGMP deviations

FDA Publishes Warning Letter with Photos

The USFDA has issued a Warning Letter to the Indian drug manufacturing facility of Patcos